EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics
If you’re just now considering the therapeutic value of psychedelics, Cybin Inc (NYSE: CYBN) is many trips ahead of you.
EXCLUSIVE: Irwin Naturals CEO Explains Importance Of Brand In Booming Psychedelics Space
One of the challenges faced by the psychedelics industry is that trauma and mental illness are tied to income,…
Irwin Naturals Adds Five Ketamine Facilities Toward Goal To Become World’s Largest Mental Health Treatment Chain
With the goal of becoming the world’s largest chain of psychedelic mental health clinics, Irwin Naturals Inc. (OTCQB: IWINF) announced the acquisition of five ketamine treatment clinics in Florida and a partnership contract with two clinics in Mexico.
EXCLUSIVE: Breaking Down Public Vs. Private Psychedelic Investments
For many private companies, the goal is clear: to go public. For others, the goal is an acquisition. Either way, private companies offer attractive potential for investors, especially in emerging markets.
And the psychedelic space is just that.
EXCLUSIVE: Enveric Offers Investors Rare Exposure To Both Cannabis And Psychedelic Industries
There were more than 30 different companies in the psychedelic space present at the inaugural Benzinga Psychedelics Capital Conference on Tuesday. But, Enveric is one of the only ones that offer investors exposure to both the psychedelic and cannabis space. Enveric Biosciences Inc (NASDAQ:
Psyched Wellness CEO Buys This Many Shares In The Open Market
Jeffrey Stevens, the CEO and co-founder of Psyched Wellness (OTCQB: PSYCF), has bought 321,000 shares of the company in the open market at CA$0.125 per share for a total cost of of CA$40,125 (around $31,750).
EXCLUSIVE: Why Kevin O’Leary Of ‘Shark Tank’ Says Public Psychedelics Companies Will Need To Merge
The market opportunity for legal psychedelics is in the hundreds of billions of dollars, “Shark Tank” judge Kevin O’Leary told the inaugural Benzinga Psychedelics Capital Conference on Tuesday. Investors never get the opportunity to position themselves in a brand new sector, “Mr.
Silo Wellness Enters Financing Arrangement With Alpha Blue Ocean
Silo Wellness (OTCQB: SILFF), a publicly-traded company that offers psychedelic retreats in Jamaica, has announced that the investing firm Alpha Blue Ocean has managed a CA$5,950,000 (around $4,720,000) financing arrangement for the company.
Mydecine Announces 1-for-50 Reverse Stock Split
The board of directors of Mydecine Innovations Group Inc. (OTCPK:MYCOF) voted in favor of completing a reverse stock split. With this action, the company will consolidate all issued and outstanding shares on a base of 1-for-50.
According to Mydecine, the consolidation is expected to reduce the number of common shares from 268,515,954 to 5,370,319.
Isracann Biosciences Acquires Praesidio Health And Appoints Natural Health Products Officers
Isracann Biosciences Inc. (OTCPK:ISCNF) (CSE:IPOT) (XFRA:A2PT0E) has closed its acquisition of Praesidio Health Inc. Pursuant to the definitive agreement dated March 24, 2022 with Praesidio and the shareholders of Praesidio, the company acquired all of the issued and outstanding shares in the capital of Praesidio for aggregate c